Replies to post #217772 on Biotech Values

[DewDiligence]

India’s Sun Pharma acquires CKPT for $4.10/sh cash +CVR—a 66% premium to Friday’s close (excluding the CVR):

https://finance.yahoo.com/news/sun-pharma-acquire-checkpoint-therapeutics-020600240.html

The nominal deal value is $355M. This is a quasi-takeunder insofar as the deal price is essentially unchanged from where CKPT was trading six years ago, despite the fact that the company gained FDA approval for its PD-1 inhibitor in SCLC.